An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease

摘要

Background Glucocorticoids (GCs) are first-line treatment for keloid disease (KD) but are limited by high incidence of resistance, recurrence and undesirable side-effects. Identifying patient responsiveness early could guide therapy.